Podcast Episodes
Back to Search
Unpacking the FDA transparency push on CRLs
The FDA made waves in early September when it announced a plan to publicly release complete response letters (CRLs) at the same time they are issued …
8 months, 3 weeks ago
How Boehringer Ingelheim is buttressing its US business
With a new president of U.S. pharma at the helm—and two key FDA approvals now in the books—Boehringer Ingelheim is sharpening its focus on the lucrat…
9 months ago
AI is changing drug safety, but governance sets the guardrails (Sponsored)
Artificial intelligence is reshaping drug safety, but governance is just as critical as innovation, according to Marie Flanagan of IQVIA Safety Techn…
9 months ago
A whirlwind week for pharma
Tariffs, drug pricing reform, a government shutdown and a major turnover at one of the world’s largest drugmakers all converged this week, leaving pl…
9 months, 1 week ago
Fierce Biotech's Fierce 15
Despite a challenging year, the biotech industry has continued to push boundaries, taking bold risks in pursuit of groundbreaking science. If anythin…
9 months, 2 weeks ago
Rebuilding trust in pharma in the age of misinformation
Trust in pharma has always been fragile, and the rise of misinformation has made it even more precarious.
In this episode of "The Top Line," recorded…
9 months, 3 weeks ago
Schrödinger taps AI to speed drug discovery (Sponsored)
Robert Abel, chief scientific officer at Schrödinger, says advanced computational tools are changing the pace and accuracy of drug discovery. In a re…
9 months, 3 weeks ago
Inside the commercial growing pains of hemophilia gene therapies
With Pfizer discontinuing Beqvez and BioMarin scaling back the commercial focus of Roctavian, the curative promise of hemophilia gene therapies is te…
9 months, 4 weeks ago
A rare kind of leadership, 30 years in the making
Hope, when applied with purpose and action, can be a powerful force for driving change in healthcare.
That’s the philosophy of Eugene Woods, CEO of A…
10 months ago
Former FDA Chief Scott Gottlieb talks drug pricing, access and innovation (Sponsored)
In the latest episode of the Health Matters podcast, former Food and Drug Administration Commissioner Scott Gottlieb joins WPP’s Wendy Lund, GCI Heal…
10 months, 1 week ago